Diabetes Registry Graz for Biomarker Research
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMedical University of Graz
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
18 - 99 years
Informed consent has to be given in written form
Type 1 diabetes
Type 2 diabetes
No written informed consent
No willingness to participate in this registry
7
Treatment groupsSee each treatment group below.